- Home
- AXSM vs HASI Comparison
AXSM vs HASI Comparison
Compare AXSM & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | HASI |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.2B |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AXSM | HASI |
|---|---|---|
| Price | $148.16 | $32.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 8 |
| Target Price | ★ $176.00 | $39.88 |
| AVG Volume (30 Days) | 526.6K | ★ 1.1M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | N/A | ★ 27.54 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $561,263,000.00 | $99,644,000.00 |
| Revenue This Year | $66.20 | $187.33 |
| Revenue Next Year | $57.56 | $16.20 |
| P/E Ratio | ★ N/A | $14.21 |
| Revenue Growth | ★ 65.83 | N/A |
| 52 Week Low | $75.56 | $21.98 |
| 52 Week High | $152.94 | $34.54 |
Technical Indicators
Market Signals| Indicator | AXSM | HASI |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 53.34 |
| Support Level | $144.00 | $32.44 |
| Resistance Level | $150.00 | $33.63 |
| Average True Range (ATR) | 4.15 | 0.71 |
| MACD | -0.73 | -0.21 |
| Stochastic Oscillator | 57.42 | 36.40 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.
HA Sustainable Infrastructure Capital Inc is an investor in sustainable infrastructure assets advancing the energy transition. Its investment is focused on actively partnering with clients to deploy capital in income-generating real assets that are supported by long-term recurring cash flows. This enabled to the generation of attractive risk-adjusted returns and provided stockholders with diversified exposure to the energy transition.